Current Illinois CancerCare Clinical Trials

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Study Number: S2303

Study Summary:
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced).

Status: Open

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621
  • Jessica, 309-243-3615,

Study Link

« Search Again